IDEXX Laboratories Expects 2024 Revenue Of $3.885B-$3.945B Versus Prior Guidance Of $3.895B-$3.965B And Consensus Of $3.936B
Portfolio Pulse from Benzinga Newsdesk
IDEXX Laboratories has updated its 2024 revenue guidance to a range of $3.885 billion to $3.945 billion, slightly lower than its previous guidance of $3.895 billion to $3.965 billion and the consensus estimate of $3.936 billion.
August 06, 2024 | 10:34 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IDEXX Laboratories has revised its 2024 revenue guidance to $3.885 billion to $3.945 billion, which is slightly lower than its previous guidance and the consensus estimate. This could lead to a short-term negative impact on the stock price.
The revised revenue guidance is slightly lower than both the previous guidance and the consensus estimate, which may lead to a negative sentiment among investors and a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100